Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rakovina Therapeutics Inc. has utilized its Deep Docking AI platform to rapidly identify promising drug candidates for cancer treatment, a process that traditionally would take thousands of years. The company plans to validate these candidates and aims to advance a best-in-class drug candidate to human trials.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.